BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36377216)

  • 1. Long Non-Coding RNA
    Kang L; Sun J; Liu J; Xu F; Zhu Q; Shi X
    Cell J; 2022 Nov; 24(11):665-672. PubMed ID: 36377216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA cancer susceptibility candidate 2 regulates the function of human fibroblast-like synoviocytes via the microRNA-18a-5p/B-cell translocation gene 3 signaling axis in rheumatoid arthritis.
    Ye Z; Wei L; Yin X; Li H; Qin G; Li S; Peng T; Liu B; Zhao S; Zhuo Q
    Bioengineered; 2022 Feb; 13(2):3240-3250. PubMed ID: 35045800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulated lncRNA CASC2 May Inhibit Malignant Melanoma Development Through Regulating miR-18a-5p/RUNX1.
    Zhang Y; Qian W; Feng F; Cao Q; Li Y; Hou Y; Zhang L; Fan J
    Oncol Res; 2019 Feb; 27(3):371-377. PubMed ID: 29422114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long non-coding RNA HOTAIRM1 suppresses cell progression via sponging endogenous miR-17-5p/ B-cell translocation gene 3 (BTG3) axis in 5-fluorouracil resistant colorectal cancer cells.
    Ren T; Hou J; Liu C; Shan F; Xiong X; Qin A; Chen J; Ren W
    Biomed Pharmacother; 2019 Sep; 117():109171. PubMed ID: 31261026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal miR-18a-5p promotes EMT and metastasis of NPC cells via targeting BTG3 and activating the Wnt/β-catenin signaling pathway.
    Zhong Q; Nie Q; Wu R; Huang Y
    Cell Cycle; 2023 Jul; 22(13):1544-1562. PubMed ID: 37287276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a/IRF-2 signaling pathway.
    Xiao XH; He SY
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3130-3142. PubMed ID: 32271431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA CASC2 is involved in the development of chronic obstructive pulmonary disease
    Liu P; Zhang H; Zeng H; Meng Y; Gao H; Zhang M; Zhao L
    Ther Adv Respir Dis; 2021; 15():17534666211028072. PubMed ID: 34266334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA CASC2 suppresses the growth of hemangioma cells by regulating miR-18a-5p/FBXL3 axis.
    Dai YX; Qiu MK; Wang SQ; Pan C; Wang Y; Ou JM
    J Biol Regul Homeost Agents; 2020; 34(1):49-56. PubMed ID: 32138500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA CASC2 inhibits cell proliferation, metastasis and EMT through miR-18a/SOCS5 axis in cholangiocarcinoma.
    Peng L; Liu YH; Nie S; Gao M
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8367-8376. PubMed ID: 32894543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAX6 upstream antisense RNA (PAUPAR) inhibits colorectal cancer progression through modulation of the microRNA (miR)-17-5p / zinc finger protein 750 (ZNF750) axis.
    Wen R; Chen C; Zhong X; Hu C
    Bioengineered; 2021 Dec; 12(1):3886-3899. PubMed ID: 34288812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CASC2 inhibits the growth, migration, and invasion of thyroid cancer cells through sponging miR-18a-5p/FIH1 axis.
    Liu QY; Gao LY; Xu L; Zhang XL; Zhang LJ; Gong XL; Luo SB; Zhao R; Cheng RC
    Kaohsiung J Med Sci; 2021 Apr; 37(4):268-275. PubMed ID: 33336500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA CASC2 targeting miR-18a suppresses glioblastoma cell growth, metastasis and EMT
    Wang J; Qin C; Zhong C; Wen Y; Ke S; Liao BO
    J Biosci; 2020; 45():. PubMed ID: 32975234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA CASC2 promotes paclitaxel resistance in breast cancer through regulation of miR-18a-5p/CDK19.
    Zheng P; Dong L; Zhang B; Dai J; Zhang Y; Wang Y; Qin S
    Histochem Cell Biol; 2019 Oct; 152(4):281-291. PubMed ID: 31352515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Molecular Mechanism of LncRNA-CASC2/miR-155-5p/APC Axis Regulating the Progression of Non-Hodgkin Lymphoma].
    Zheng CJ; Wu ZM; Wang YS; Hou YX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1939-1945. PubMed ID: 33283723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA CASC2 enhanced cisplatin-induced viability inhibition of non-small cell lung cancer cells by regulating the PTEN/PI3K/Akt pathway through down-regulation of miR-18a and miR-21.
    Li L; Zhang H; Wang X; Wang J; Wei H
    RSC Adv; 2018 Apr; 8(29):15923-15932. PubMed ID: 35542225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA CASC2 restrains high glucose-induced proliferation, inflammation and fibrosis in human glomerular mesangial cells through mediating miR-135a-5p/TIMP3 axis and JNK signaling.
    Zhu D; Wu X; Xue Q
    Diabetol Metab Syndr; 2021 Aug; 13(1):89. PubMed ID: 34446088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-145-5p restrained cell growth, invasion, migration and tumorigenesis via modulating RHBDD1 in colorectal cancer via the EGFR-associated signaling pathway.
    Niu Y; Zhang J; Tong Y; Li J; Liu B
    Int J Biochem Cell Biol; 2019 Dec; 117():105641. PubMed ID: 31693935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA KCNQ1OT1 acts as miR-216b-5p sponge to promote colorectal cancer progression via up-regulating ZNF146.
    Zhu S; Chen CY; Hao Y
    J Mol Histol; 2021 Jun; 52(3):479-490. PubMed ID: 33394291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA DANCR accelerates colorectal cancer progression via regulating the miR-185-5p/HMGA2 axis.
    Lu W; Huang Z; Wang J; Liu H
    J Biochem; 2022 Mar; 171(4):389-398. PubMed ID: 33481014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-335-5p Inhibits Cell Proliferation, Migration and Invasion in Colorectal Cancer through Downregulating LDHB.
    Zhang D; Yang N
    J BUON; 2019; 24(3):1128-1136. PubMed ID: 31424671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.